Skip to content

Medical-device intelligence

Instrumentation Laboratory Co.: FDA clearances and recalls

Research Instrumentation Laboratory Co. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

320 clearance records and 58 recall records in the covered releases, across 1 source company names and 139 product codes. Dated history runs from Jul 20, 1976 to Sep 29, 2023.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

378 matching records
Device / recordCompany in FDA recordSourceSource date
COAMATIC AT-400K022195 · JBQInstrumentation Laboratory CO510(k)Aug 7, 2002FDA decision date
HEMOSIL HIGH ABNORMAL CONTROL ASSAYEDK021024 · GGNInstrumentation Laboratory CO510(k)May 16, 2002FDA decision date
HEMOSIL LOW ABNORMAL CONTROLLED (ASSAYED); HEMOSIL LOW ABNORMAL CONTROL 2 (UNASSAYED)K021022 · GGNInstrumentation Laboratory CO510(k)May 14, 2002FDA decision date
HEMOSIL NORMAL CONTROL (ASSAYED); HEMOSIL NORMAL CONTROL 1 (UNASSAYED)K021023 · GGNInstrumentation Laboratory CO510(k)May 14, 2002FDA decision date
COLOR-MONOGENK012901 · KTNInstrumentation Laboratory CO510(k)Sep 27, 2001FDA decision date
HEMOSIL RECOMBI PLASTINK012768 · GJSInstrumentation Laboratory CO510(k)Sep 18, 2001FDA decision date
IL TEST PROSK011424 · GGPInstrumentation Laboratory CO510(k)Jun 25, 2001FDA decision date
GEM PREMIER 3000- ADDITION OF GLUCOSE AND LACTATE AS NEW PARAMETERSK010520 · CGAInstrumentation Laboratory CO510(k)May 7, 2001FDA decision date
IL TEST FREE PROTEIN SK010379 · GGPInstrumentation Laboratory CO510(k)Apr 13, 2001FDA decision date
COALIZA PROTEIN S-FREEK002467 · GGPInstrumentation Laboratory CO510(k)Oct 13, 2000FDA decision date
MODIFICATION OF ACL ADVANCEK002400 · JPAInstrumentation Laboratory CO510(k)Aug 30, 2000FDA decision date
IL TEST LIQUID ANTITHROMBINK994238 · JBQInstrumentation Laboratory CO510(k)Jun 23, 2000FDA decision date
ACL 9000 SYSTEMK000053 · JPAInstrumentation Laboratory CO510(k)Mar 15, 2000FDA decision date
GEM PREMIER 3000K992834 · CHLInstrumentation Laboratory CO510(k)Nov 24, 1999FDA decision date
IL TEST VON WILLEBRAND FACTORK992704 · GGPInstrumentation Laboratory CO510(k)Nov 1, 1999FDA decision date
IL TEST LAC SCREEN (CLAIMS ADDED TO ACL FUTURA), IL TEST LAC CONFIRM (CLAIMS ADDAD TO ACL FUTURA)K990302 · GIRInstrumentation Laboratory CO510(k)Apr 8, 1999FDA decision date
QUANTEX ASO-CRP-RP CONTROL IIK984437 · JJTInstrumentation Laboratory CO510(k)Feb 2, 1999FDA decision date
COAMATIC HEPARINK983178 · KFFInstrumentation Laboratory CO510(k)Nov 3, 1998FDA decision date
COAMATIC PLASMIN INHIBITORK981817 · GGPInstrumentation Laboratory CO510(k)Sep 28, 1998FDA decision date
IL TEST PLASMIN INHIBITORK981696 · GGPInstrumentation Laboratory CO510(k)Aug 27, 1998FDA decision date
TOXOGENK981263 · GMMInstrumentation Laboratory CO510(k)Aug 6, 1998FDA decision date
IL TEST PT-FIBRINOGEN RECOMBINANTK981479 · GJSInstrumentation Laboratory CO510(k)Jul 7, 1998FDA decision date
IL TEST PLASMINOGENK981200 · GGPInstrumentation Laboratory CO510(k)May 26, 1998FDA decision date
IL SYNTHESIS--ADDITION OF BILIRUBIN AS A MEASURED PARAMETER FOR NEONATE WHOLE BLOOD SAMPLESK980646 · MQMInstrumentation Laboratory CO510(k)May 6, 1998FDA decision date
CMVGENK974456 · LJOInstrumentation Laboratory CO510(k)May 1, 1998FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗